期刊文献+

恶性肿瘤患者医院获得性屎肠球菌血流感染临床特点与死亡危险因素分析 被引量:2

Clinical characteristics and risk factors for mortality of malignancy patients with nosocomial Enterococcus faecium bloodstream infections
原文传递
导出
摘要 目的探讨恶性肿瘤合并医院获得性屎肠球菌血流感染患者的临床特点及其死亡危险因素。方法回顾性收集2012年1月-2015年12月恶性肿瘤合并医院获得性屎肠球菌血流感染93例患者的临床资料,采用logistic回归分析死亡危险因素。结果 93例患者中肿瘤类型为实体肿瘤82例占88.17%;伴有发热患者86例占92.47%,伴有寒颤患者56例占60.22%;白细胞计数和(或)中性粒细胞计数升高84例占90.32%,C-反应蛋白(CRP)升高89例占95.70%;继发性血流感染61例占65.59%;药敏数据显示,对万古霉素的耐药率为5.63%,无替考拉宁和利奈唑胺耐药菌株;30天病死率为26.88%;单因素分析显示入住ICU、肾功能不全、查尔森合并指数(CCI)、急性生理慢性健康评分(APACHEⅡ)、继发血流感染、发病前30天内行外科手术、化疗、机械通气、气管插管/切开和留置尿管与死亡相关(P<0.05);多因素logistic回归分析显示仅APACHE II评分与死亡相关(P<0.001)。结论恶性肿瘤合并医院获得性屎肠球菌血流感染患者的临床特点主要有发热、寒颤、白细胞和(或)中性粒细胞升高、CRP升高;屎肠球菌分离株对万古霉素、替考拉宁和利奈唑胺均敏感;高APACHEⅡ评分是死亡的独立危险因素。 OBJECTIVE To investigated the clinical characteristics and risk factors for mortality of malignancy patients with nosocomial Enterococcus faecium bloodstream infections(BSI).METHODS The clinical data of malignancy patients with nosocomial E.faecium BSI were collected from Jan.2012 to Dec.2015.The risk factors for mortality were analyzed by logistic regression analysis.RESULTS There were 93 malignancy patients enrolled in this study.The main tumor types were solid tumors which accounting for 82 cases(88.17%).There were 86 cases(92.47%)of these patients with fever,56 cases(65.12%)with chill;84 cases(90.32%)with leukocytes and/or granulocytes increased,and 89 cases(95.70%)with C-reactive protein increased.Most of the patients(61 cases,65.59%)were secondary bloodstream infections.Drug sensitivity results showed,resistant rate to vancomycin was 5.63%.All these E.faeciumisolates were sensitive to both teicoplanin and linezolid.The 30-day mortality rate was as high as 26.88%.The univariate analysis showed that enrolled in ICU,renal function insufficiency,CCI score,APACHEⅡscore,secondary BSI,surgery at 30 days before the onset,chemotherapy,mechanical ventilation,tracheal intubation/tracheotomy and indwelling catheter were associated with the mortality(P 0.05).Multivariate logistic regression analysis showed that only APACHEⅡscore was associated with the mortality(P〈0.001).CONCLUSION The clinical features of malignancy patients with nosocomial E.faecium BSI include fever,chill,leukocytes and/or granulocytes increased,and C-reactive protein increased.These isolates are sensitive to vancomycin,teicoplanin and linezolid.For malignancy patients with nosocomial E.faecium BSI,high APACHEⅡ score is an independent risk factor for the mortality.
作者 张洋洋 杜明梅 刘运喜 吴珍 梁志欣 ZHANG Yang-yang DU Ming-mei LIU Yun-xi WU Zhen LIANG Zhi xin(Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, Chin)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2017年第20期4618-4621,共4页 Chinese Journal of Nosocomiology
基金 军队十二五基金资助项目(BWS14J040)
关键词 屎肠球菌 医院获得性感染 血流感染 临床特征 死亡危险因素 Enterococcus faecium Nosocomial infection Bloodstream infections Clinical characteristics Mortali-ty risk factors
  • 相关文献

参考文献3

二级参考文献35

  • 1Thong KL, Lai MY, Teh C SJ, et al. Simultaneous detection of methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Psendomonas aeruginosa by muhiplex PCR [ J ] . Trop Biomed, 2011, 28 ( 1 ) : 21-31.
  • 2Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection : a population-based study in Olmsted County, Minnesota [ J ] . Arch Intern Med, 2007, 167 ( 8 ) : 834- 839.
  • 3Mar t n M, Gudiol C, Garcia-Vidal C, et al. Bloodstream infections in patients with solid tumors : epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center [ J ]. Medicine ( Baltimore ) , 2014, 93 ( 3 ) : 143-149.
  • 4Hirsch EB, Cottreau JM, Chang KT, et al. A model to predict mortality following Pseudomonas aeruginosa haeteremia [ J ] . Diagn Microbiol Infect Dis, 2012, 72 ( 1 ) : 97-102.
  • 5Kang CI, Kim SH, Kim HB, et al. Pseudomonas aeruginosa baeteremia : risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome [ J ] . Clin Infect Dis, 2003, 37 ( 6 ) : 745-751.
  • 6Willmann M, Kuebart I, Vogel W, et al. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection [ J ]. J Infect, 2013, 67 ( 5 ) : 416-423.
  • 7Su TY, Ye JJ, Hsu PC, et al. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia [ J ] . J Microbiol Immunol Infect, 2015, 48 ( 2 ) : 175- 182.
  • 8Parkins MD, Gregson DB, Pitout JD, et al. Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection [ J ] . Infection, 2010, 38 ( 1 ) : 25-32.
  • 9Morata L, Cobos-Trigueros N, Mart e nez JA, et al. Influence of multidrug resistance and appropriate empirical therapy on the 30- day mortality rate of Pseudomonas aeruginosa bacteremia [ J ] . Antimicrob Agents Chemother, 2012, 56 ( 9 ) : 4833-4837.
  • 10Tam VII, Rogers CA, Chang KT, et al. Impact of muhidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes [ J ] . Antimicrob Agents Chemother, 2010, 54 ( 9 ) : 3717-3722.

共引文献14

同被引文献23

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部